Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
Authors:
Open Access
- 1 September 2023
- journal article
- research article
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 30 (9) , 1142-1151
Abstract
Aim: This study aimed to reveal whether a larger postprocedural minimum lumen area (MLA) would reduce restenosis risk after endovascular therapy (EVT) using drug-coated balloons (DCBs) in femoropopliteal (FP) lesions. Methods: This retrospective, nonrandomized, single-arm, and multicenter registry analyzed patients with FP lesions undergoing intravascular ultrasound (IVUS)-guided EVT with DCB between 2017 and 2021. The primary outcome was restenosis 1 year after EVT. The association between IVUS-based MLA and restenosis risk was investigated using a generalized propensity score (GPS) method to address imbalance of baseline covariates. The dose-response function of IVUS-measured MLA for restenosis risk was developed using the GPS-adjusted Cox proportional hazards regression model. Results: This study enrolled consecutive 489 patients with 595 lesions undergoing DCB treatment. The median MLA (interquartile range) was 13.20 (9.90-16.91) mm2. Kaplan-Meier estimates showed that freedom from restenosis was 84.4% at 1 year. The GPS-adjusted dose-response function showed that MLA was inversely associated with restenosis risk. The upper limit of 95% confidence interval (CI) of the slope was lower than 0 between 10.6 and 17.0 mm2 of MLAs. The 1-year cumulative incidence of restenosis was estimated to be 9.8% (95% CI, 5.8%-13.7%) for the 3rd quartile of MLA (16.91 mm2) versus 18.5% (12.3%-24.1%) for the 1st quartile (9.90 mm2), with a hazard ratio of 0.51 (95% CI, 0.39-0.67; p<0.001). Conclusions: The present GPS analysis suggested that larger IVUS-measured MLA might be associated with lower risk of 1-year restenosis after DCB treatment for FP lesions.Keywords
This publication has 23 references indexed in Scilit:
- Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal ArteriesCirculation: Cardiovascular Interventions, 2018
- Impact of Stent-to-Vessel Diameter Ratio on Restenosis in the Superficial Femoral Artery After Endovascular TherapyCirculation Journal, 2018
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)Polish Heart Journal, 2017
- Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery diseaseJournal of Vascular Surgery, 2016
- Intravascular Ultrasound–Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral ArteryJournal of Endovascular Therapy, 2016
- Drug-Coated Balloons for Complex Femoropopliteal LesionsJACC: Cardiovascular Interventions, 2016
- Calcium Burden Assessment and Impact on Drug-Eluting Balloons in Peripheral Arterial DiseaseCardioVascular and Interventional Radiology, 2014
- Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implicationsCatheterization and Cardiovascular Interventions, 2014
- Dialysis Outcomes and Practice Patterns Study (DOPPS)Clinical Journal of the American Society of Nephrology, 2012
- The Propensity Score with Continuous Treatments2004